Purine ribosides as antiarrhythmics

Details for Australian Patent Application No. 2001292591 (hide)

International Classifications

Event Publications

3 June 2004 Application Accepted

Published as AU-B-2001292591

30 September 2004 Standard Patent Sealed

15 October 2009 Amendment Made

The nature of the amendment is: Amend the patentee name from CV Therapeutics, Inc. to Gilead Palo Alto, Inc. 2002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.